Introduction
============

Within-person variation in headache (HA) frequency and the nature and predictors of this variation have rarely been studied.

Aims
====

To determine variation and predictors of HA days/month in persons with episodic (EM) or chronic migraine (CM).

Methods
=======

CaMEO was a longitudinal US survey employing quota sampling for screening 80,783 respondents to identify persons with migraine. Baseline HA day frequency was classified as EM (modified ICHD-3b migraine diagnosis, \<15 HA days/month for past 3 months) or CM (modified ICHD-3b diagnosis, ≥15 HA days/month for past 3 months). Migraineurs completed quarterly surveys over 5 waves (\~1 year) assessing HA symptoms and frequency. Using repeated measures regression modeling, we describe variation in HA days within/between individuals, and evaluate potential variation predictors.

Results
=======

From 58,418 useable returns, we identified 16,789 migraineurs at baseline (EM: 15,313 \[91.2%\], CM: 1,476 \[8.8%\]). The reported number of HA days/month showed cyclic variation over time within and between respondents with both CM and EM. HA days increased more for CM (vs EM) persons over time (quarterly RR=1.26, 95% CI 1.20--1.33; P\<0.0001). A comprehensive graphical decomposition of this interaction will be presented.

Conclusion
==========

Substantial within- and between-person heterogeneity in quarterly estimates of HA days/month was observed, and resulting trajectories differed between groups. The number of HA days/month increased 26% more per quarter for persons with CM vs EM, possibly resulting from a lowered threshold for migraine initiation, creating positive feedback leading to more attacks.
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